Equity Research

Matt Phipps Guests on CNBC

William Blair research analyst Matt Phipps joined CNBC’s “Worldwide Exchange” to discuss the implications for pharmaceutical companies that have their drugs listed on Medicare’s price negotiation roster.

Our Latest News

Tuesday, April 22, 2025

Tracking Job Openings and Staffing Demand Trends

Global services analyst Trevor Romeo, CFA discusses the impact of recent economic uncertainties on the staffing industry, highlighting key trends and challenges faced by companies and exploring the evolving landscape of job openings and the future of staffing.
Listen to the podcast
Monday, April 21, 2025

William Blair Initiates Coverage of Two Biotech Companies

William Blair initiated research coverage of Context Therapeutics Inc. (CNTX $0.84) and Xencor, Inc. (XNCR $9.70), two biotech companies focused on the development of T-cell engagers (TCEs) for solid tumor indications.
Read more
Monday, April 21, 2025

Zillow Group, Inc.: Initiation of Research Coverage

William Blair initiated research coverage of Zillow Group, Inc. (Z $62.47), the leader among home search portals in visitor traffic.
Read more

See more news

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures

William Blair Thinking

William Blair Thinking Podcast

William Blair Thinking

Matt Phipps Guests on CNBC

Our Latest News

Tracking Job Openings and Staffing Demand Trends

William Blair Initiates Coverage of Two Biotech Companies

Zillow Group, Inc.: Initiation of Research Coverage

Are you sure you want to leave?